Fred Lee

Fred Lee

Private Equity Investor at Revelation Partners LLC

Finance
Consumer Services

Profile

Fred is the Managing Director, Head of Business Origination at Revelation Partners.
With over 15 years of banking and investment experience, Fred focuses on identifying and reviewing new investment opportunities, as well as managing the firm’s industry relationships.
Fred is responsible for leading recent investments in Headspace Health, Cityblock, Akili, Click Therapeutics, SomaLogic, and Synthego.
Prior to Revelation Partners, Fred was a Managing Director in the Life Sciences Group at Bridge Bank, where he executed venture debt investments across all healthcare sectors.
Fred began his career in the Healthcare Investment Banking group at Citi, where he advised on a number of M&A and financing transactions for both public and private healthcare clients.
Fred received a BS in Business Administration and BA in Economics from the University of California, Berkeley.
? When not working with healthcare companies and investors, Fred enjoys running, playing basketball, and snowboarding.
He lives in Orinda, California, with his wife and two young children.

Fred Lee active positions

CompaniesPositionStart
Private Equity Investor 2018-05-31
All active positions of Fred Lee

Former positions of Fred Lee

CompaniesPositionEnd
Bridge Bank Ltd. Private Equity Investor 2018-07-01
Private Equity Investor 2016-07-01
Private Equity Investor 2015-11-30
CITIGROUP INC. Private Equity Investor 2014-06-01
See the detail of Fred Lee's experience

Training of Fred Lee

University of California, Berkeley Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fred Lee's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CITIGROUP INC.

Finance

Private companies4

Finance

Finance

Finance

Bridge Bank Ltd.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW